This proposal was prompted by two recent findings by this laboratory which demonstrate the uniqueness of polyamine catabolism in human tumor cells: (1) contrary to dogma based on studies with rodent tissues, polyamine oxidation rather than polyamine acetylation appears to be the rate-limiting enzyme activity in intracellular polyamine catabolism and (2) in many human tumor cell lines, the polyamine catabolizing enzyme, spermidine/spermine N1-acetyltransferase (SSAT) displays an inducibility in response to polyamine analogs which is highly unique in its rapidity (hrs), magnitude (100 to 60,000 pmol/mg/min) and heterogeneity among cell lines. This proposal will attempt to characterize inducible polyamine metabolism in human tumor cells from mechanistic, metabolic and cellular perspectives. More specifically, we propose (a) to survey the prevalence of SSAT superinducibility among various tumor cell lines and seek a commonality for it, (b) to purify the SSAT protein from a human cell line (already accomplished for one cell line) and develop antibodies to it (underway); (c) to study the mechanistic basis for differential responsiveness to SSAT inducibility among different cell lines; (d) to evaluate the metabolic consequences of SSAT induction and its relationship to cell proliferation; (e) to examine in vivo SSAT inducibility of SSAT in human tumor zenografts and to compare it with that of normal tissues and (f) to examine polyamine catabolism in normal and neoplastic human tissue samples. The proposed studies will entail tissue culture techniques, enzyme assays, HPLC methodology, protein purification techniques, antibody development and human xenograft studies in nude mice. Ultimately, these studies are designed to determine whether inducible polyamine catabolism has relevance in monitoring or treating human malignancies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051524-02
Application #
3196291
Study Section
Biochemistry Study Section (BIO)
Project Start
1990-07-01
Project End
1993-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Porter, C W; Bernacki, R J; Miller, J et al. (1993) Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res 53:581-6
Shappell, N W; Fogel-Petrovic, M F; Porter, C W (1993) Regulation of spermidine/spermine N1-acetyltransferase by intracellular polyamine pools. Evidence for a functional role in polyamine homeostasis. FEBS Lett 321:179-83
Fogel-Petrovic, M; Shappell, N W; Bergeron, R J et al. (1993) Polyamine and polyamine analog regulation of spermidine/spermine N1-acetyltransferase in MALME-3M human melanoma cells. J Biol Chem 268:19118-25
Fogel-Petrovic, M; Kramer, D L; Ganis, B et al. (1993) Cloning and sequence analysis of the gene and cDNA encoding mouse spermidine/spermine N1-acetyltransferase--a gene uniquely regulated by polyamines and their analogs. Biochim Biophys Acta 1216:255-64
Bernacki, R J; Bergeron, R J; Porter, C W (1992) Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res 52:2424-30
Shappell, N W; Miller, J T; Bergeron, R J et al. (1992) Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res 12:1083-9
Libby, P R; Ganis, B; Bergeron, R J et al. (1991) Characterization of human spermidine/spermine N1-acetyltransferase purified from cultured melanoma cells. Arch Biochem Biophys 284:238-44
Porter, C W; Ganis, B; Libby, P R et al. (1991) Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res 51:3715-20